BIOMAT Database Logo BIOMAT Database Logo

A trial of oxyphenbutazone eye ointment in general practice. 1973

D G Emery, and V H Smith, and P Wilkinson

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009824 Ointments Semisolid preparations used topically for protective emollient effects or as a vehicle for local administration of medications. Ointment bases are various mixtures of fats, waxes, animal and plant oils and solid and liquid hydrocarbons. Ointment,Paste,Pastes,Salve,Unguent,Salves,Skin Ointment,Unguents,Ointment, Skin
D010113 Oxyphenbutazone A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. (From AMA, Drug Evaluations Annual, 1994, p2000) It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p27) Hydroxyphenylbutazone,Diflamil,Oxyphenylbutazone,Tanderil
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D005128 Eye Diseases Diseases affecting the eye. Eye Disorders,Eye Disease,Eye Disorder
D005194 Family Practice A medical specialty concerned with the provision of continuing, comprehensive primary health care for the entire family. Family Practices,Practice, Family,Practices, Family

Related Publications

D G Emery, and V H Smith, and P Wilkinson
Oxyphenbutazone eye ointment.
November 1984, Drug and therapeutics bulletin,
D G Emery, and V H Smith, and P Wilkinson
Oxyphenbutazone (tanderil) eye ointment.
October 1972, Drug and therapeutics bulletin,
D G Emery, and V H Smith, and P Wilkinson
Oxyphenbutazone eye-ointment in the treatment of foreign bodies in the cornea.
January 1973, Acta ophthalmologica,
D G Emery, and V H Smith, and P Wilkinson
Tanderil/chloramphenicol eye ointment in the treatment of the "Red Eye" seen in general practice.
January 1978, The Journal of international medical research,
D G Emery, and V H Smith, and P Wilkinson
[Trial use of a nystatinchloramphenicol eye ointment].
June 1963, Rinsho ganka. Japanese journal of clinical ophthalmology,
D G Emery, and V H Smith, and P Wilkinson
A multi-centre general practice trial comparing Fucidin Ointment and Fucidin Cream.
April 1981, The British journal of clinical practice,
D G Emery, and V H Smith, and P Wilkinson
[Phenylbutazone ointment in general medical practice].
March 1971, Orvosi hetilap,
D G Emery, and V H Smith, and P Wilkinson
[Experiences with Ossidal ointment in general practice].
October 1967, Der Landarzt,
D G Emery, and V H Smith, and P Wilkinson
Proceedings: A new possibility to treat superficial eye injuries with an ointment, presenting the advantages, but not the disadvantages of local application of corticosteroids. A double-blind trial in the effect of oxyphenbutazone 10 percent eye ointment (Tanderil) as a therapy in superficial eye injuries.
January 1973, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde,
D G Emery, and V H Smith, and P Wilkinson
[Use of oxyphenbutazone in eye surgery].
January 1969, La Prensa medica mexicana,
Copied contents to your clipboard!